Recast Therapy for Developmental Language Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Developmental Language DisorderRecast Therapy - Behavioral
Eligibility
4 - 9
All Sexes
What conditions do you have?
Select

Study Summary

This trial will examine alternative methods of delivering treatment for Developmental Language Disorder (DLD) in order to identify implementation barriers and improve long-term outcomes.

Eligible Conditions
  • Developmental Language Disorder

Treatment Effectiveness

Study Objectives

4 Primary · 6 Secondary · Reporting Duration: within 2 weeks post therapy ( ~12- 14 week mark in study timeline)

Week 2
Change in Comprehension probes (Pointing)
Change in Comprehension probes (Proportion Looking)
Week 2
Change in Accuracy on Elicited Production Probes
Week 10
Estimated Dose Delivered
Week 10
Effortfulness of treatment
Palatability of treatment
self-efficacy of treatment provider
Week 5
Caregiver grammar knowledge
Week 14
Semi-structured interviews
Theoretical Domains Framework (TDF) Questionnaire

Trial Safety

Trial Design

4 Treatment Groups

Recast Therapy Provided By Clinician
1 of 4
Illustrated Syntax Stories Provided by a Caregiver
1 of 4
Illustrated Syntax Stories Provided by Clinician
1 of 4
Recast Therapy Provided by a Caregiver
1 of 4

Experimental Treatment

160 Total Participants · 4 Treatment Groups

Primary Treatment: Recast Therapy · No Placebo Group · N/A

Recast Therapy Provided By Clinician
Behavioral
Experimental Group · 1 Intervention: Recast Therapy · Intervention Types: Behavioral
Illustrated Syntax Stories Provided by a Caregiver
Behavioral
Experimental Group · 1 Intervention: Syntax Stories · Intervention Types: Behavioral
Illustrated Syntax Stories Provided by Clinician
Behavioral
Experimental Group · 1 Intervention: Syntax Stories · Intervention Types: Behavioral
Recast Therapy Provided by a Caregiver
Behavioral
Experimental Group · 1 Intervention: Recast Therapy · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: within 2 weeks post therapy ( ~12- 14 week mark in study timeline)

Who is running the clinical trial?

University of Maryland, College ParkOTHER
141 Previous Clinical Trials
41,167 Total Patients Enrolled
University of DelawareLead Sponsor
135 Previous Clinical Trials
36,611 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
282 Previous Clinical Trials
175,552 Total Patients Enrolled

Eligibility Criteria

Age 4 - 9 · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are primarily English speaking.
You have a nonverbal intelligence quotient (IQ) within the typical range as documented by a t-score at or above 35 on the Developmental Abilities Scale (DAS), matrices similarities subscale.
You have a score of 15 or higher on the Social Communication Questionnaire.
The child has no diagnosis of significant sensory-motor concerns or significant psychiatric disorders per parent report.
You have a score below 40% on a test of your own devising.